CancerDetect

CancerDetect is a blood-based test leverages genomic information from patient’s tumor tissue to monitor cancer recurrence after surgery or treatment. It is capable of identifying even the slightest presence of cancer DNA in your blood, prior to the occurrence of symptoms or the detection by conventional tests.

The test is most beneficial for individuals with stage I to III solid tumors, helping both patients and physicians better understand post-treatment health and detect recurrence earlier than with radiological imaging.

How CancerDetect Works?

CancerDetect™ employs state-of-the-art technology to find evidence of cancer coming back in your body. Here’s how it works:

1. You give tissue and blood samples.
2. Scientists employ NGS technology to identify individual cancer mutations in your tissue.
3. Your DNA gets its own personalized panel, monitoring up to 500 targets (but usually 100).
4. Your blood is scanned for these specific cancer signals with hybrid-capture technology.
5. Results are reported to your doctor, with clean explanations and follow-up.

How CancerDetect™ Stands Out?

CancerDetect™ has significant benefits compared to other cancer monitoring platforms. CancerDetect™ can monitor as many as 500, with wider and more adaptable monitoring. It employs hybrid-capture technology, which allows comprehensive coverage of the entire region of targeted genes without a limit of detection region, enabling a more precise and deeper scan for patient specific genomic mutations.

Researched and Real Results

CancerDetect™ is backed by Korea’s largest prospective study in colorectal cancer with approximately 3,000 patients. In addition to colorectal cancer, CancerDetect™ is actively used in various other solid tumors such as breast and gastric cancers, and its clinical utility has been validated through many national funded clinical studies globally.

This positions CancerDetect™ as one of the most reliable instruments for testing whether cancer can recur even before a complete blood count or uric acid test indicates changes.

Who Should Use CancerDetect™?

• Stage I-III Solid tumor patients who has finished surgery and/or chemotherapy
• Individuals who want to watch out for the recurrence of cancer with greater certainty
• Those who seek beyond simple tests such as urinalysis or fecalysis test

Act Early with Medi Linx

Silently, cancer may come back. With CancerDetect™, you have the authority to detect it early and own your healing. Medi Linx brings cutting-edge tests such as CancerDetect™ within reach. We are your go-to partner for executive check-up as well as high-end diagnostics.